Philip S - Search Results

1

Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE).

Ambrosy AP, Malik UI, Thomas RC, Parikh RV, Tan TC, Goh CH, Selby VN, Solomon MD, Avula HR, Fitzpatrick JK, Skarbinski J, Philip S, Granowitz C, Bhatt DL, Go AS. Ambrosy AP, et al. Among authors: philip s. Am Heart J. 2021 May;235:54-64. doi: 10.1016/j.ahj.2021.01.018. Epub 2021 Jan 28. Am Heart J. 2021. PMID: 33516752 Free PMC article.

2

Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects Upon High-Sensitivity C-Reactive Protein and Lipid Parameters in Patients With Metabolic Syndrome.

Bays HE, Ballantyne CM, Braeckman RA, Stirtan WG, Doyle RT Jr, Philip S, Soni PN, Juliano RA. Bays HE, et al. Among authors: philip s. Metab Syndr Relat Disord. 2015 Aug;13(6):239-47. doi: 10.1089/met.2014.0137. Epub 2015 Apr 20. Metab Syndr Relat Disord. 2015. PMID: 25893544 Clinical Trial.

3

Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies.

Ballantyne CM, Bays HE, Braeckman RA, Philip S, Stirtan WG, Doyle RT Jr, Soni PN, Juliano RA. Ballantyne CM, et al. Among authors: philip s. J Clin Lipidol. 2016 May-Jun;10(3):635-645.e1. doi: 10.1016/j.jacl.2016.02.008. Epub 2016 Feb 23. J Clin Lipidol. 2016. PMID: 27206952 Free article. Clinical Trial.

4

A novel cost-effectiveness model of prescription eicosapentaenoic acid extrapolated to secondary prevention of cardiovascular diseases in the United States.

Philip S, Chowdhury S, Nelson JR, Benjamin Everett P, Hulme-Lowe CK, Schmier JK. Philip S, et al. J Med Econ. 2016 Oct;19(10):1003-10. doi: 10.1080/13696998.2016.1207652. Epub 2016 Jul 15. J Med Econ. 2016. PMID: 27352086 Free article.

5

Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies.

Ballantyne CM, Bays HE, Philip S, Doyle RT Jr, Braeckman RA, Stirtan WG, Soni PN, Juliano RA. Ballantyne CM, et al. Among authors: philip s. Atherosclerosis. 2016 Oct;253:81-87. doi: 10.1016/j.atherosclerosis.2016.08.005. Epub 2016 Aug 20. Atherosclerosis. 2016. PMID: 27596132 Free article. Clinical Trial.

6

Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials).

Mosca L, Ballantyne CM, Bays HE, Guyton JR, Philip S, Doyle RT Jr, Juliano RA. Mosca L, et al. Among authors: philip s. Am J Cardiol. 2017 Feb 1;119(3):397-403. doi: 10.1016/j.amjcard.2016.10.027. Epub 2016 Nov 1. Am J Cardiol. 2017. PMID: 27939227 Free article. Clinical Trial.

7

Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis.

Brinton EA, Ballantyne CM, Guyton JR, Philip S, Doyle RT Jr, Juliano RA, Mosca L. Brinton EA, et al. Among authors: philip s. J Womens Health (Larchmt). 2018 Sep;27(9):1170-1176. doi: 10.1089/jwh.2017.6757. Epub 2018 Mar 27. J Womens Health (Larchmt). 2018. PMID: 29583081 Free PMC article. Clinical Trial.

8

Increased Cardiovascular Risk in Hypertriglyceridemic Patients With Statin-Controlled LDL Cholesterol.

Nichols GA, Philip S, Reynolds K, Granowitz CB, Fazio S. Nichols GA, et al. Among authors: philip s. J Clin Endocrinol Metab. 2018 Aug 1;103(8):3019-3027. doi: 10.1210/jc.2018-00470. J Clin Endocrinol Metab. 2018. PMID: 29850861

9

Comparison of Medical Care Utilization and Costs Among Patients With Statin-Controlled Low-Density Lipoprotein Cholesterol With Versus Without Hypertriglyceridemia.

Nichols GA, Philip S, Reynolds K, Granowitz CB, O'Keeffe-Rosetti M, Fazio S. Nichols GA, et al. Among authors: philip s. Am J Cardiol. 2018 Oct 1;122(7):1128-1132. doi: 10.1016/j.amjcard.2018.06.029. Epub 2018 Jul 5. Am J Cardiol. 2018. PMID: 30086877 Free article.

10

Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol.

Nichols GA, Philip S, Reynolds K, Granowitz CB, Fazio S. Nichols GA, et al. Among authors: philip s. Diabetes Obes Metab. 2019 Feb;21(2):366-371. doi: 10.1111/dom.13537. Epub 2018 Oct 14. Diabetes Obes Metab. 2019. PMID: 30225881 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

598 results

Search Page

Filters